Global Needle-free IV Connectors Market Analysis based on Healthcare Applications 2026
Needle-Free IV
Connectors are routinely used in the hospitals for intravenous
administration of fluids and medicines to protect the hubs in
vascular access systems. In order to reduce risks of possible
contaminations associated with the IV administration and to curb
manipulation as much as possible, needle free IV connectors can prove
to be ideal in all types of IV infusions. Furthermore, technological
advancements such as connectors that prevent fluid reflux, highly
closed systems, and connectors embedded with antimicrobial agents
(V-Link) have helped to decrease the risk of bloodstream infections
associated with IV administration. Needle-free connectors are with
extended dwell time that can help preventing intraluminal
contamination and device cross-contamination, which can be favorable
for the growth of the market in the near future.
Get HOLISTIC
Request Sample Copy Of This Business Report:
Market
Dynamics
Government
organizations and regulatory bodies namely Centers for Disease
Control and prevention (CDC) have recommended the usage of
needle-free connectors to reduce the incidence of sharp injuries and
blood stream infections mandating its usage in medical facilities in
the ‘Guidelines for the Prevention of Intravascular
Catheter-Related Infections’ in 2011. Major issues associated with
the conventional options of intravenous infusion are contamination
from external sources during administration, blood reflux, and risk
of bloodstream infections, which are addressed by needle-free IV
connectors. The National Healthcare Safety Network (NHSN) conducts
various programs worldwide that helps to impart education and hands
on training sessions to all physicians and nurses about the usage of
needle-free connectors and insertion of central venous catheters in
children and adults. The advantages of needle-free IV connectors over
conventional IV administration namely, safer access to IV lines
without using needle, reduced risk of bloodstream infections and
reduced possibility of contamination, rising chronic diseases
prevalence and cost containment through use of needle-free IV
connectors is expected to boost the growth of needle-free IV
connectors market over the forecast period.
Some major
players operating in the needle-free IV connectors market are
Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson
and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical
LLC, RyMed Technologies, LLC, and Vygon SA.
Market
Taxonomy
This report segments
the global IV Connectors (Needle-free) market on the basis of design
type, mechanism, and dwell time. On the basis of design type, the
global needle-free IV connectors market is segmented into Simple and
Complex. Mechanisms of needle-free IV connectors include positive,
negative, and neutral. Needle-free IV connectors are segmented by
dwell time as seven-day dwell time and other than seven-day.
Key features
of the study:
-
This report provides in-depth analysis of needle-free IV connectors and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year
-
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
-
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
-
It profiles leading players in the global Needle-Free IV Connectors market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
-
Key companies covered as a part of this study include Baxter International, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, CareFusion Corporation, ICU Medical, Inc., Nexus Medical LLC, RyMed Technologies, LLC, and Vygon SA
According to the
World Health Organization (WHO), annually around 1 million deaths are
associated with the improper use of syringes and needles, which can
be prevented by using needle-free IV connectors. Harmful diseases
namely hepatitis and HIV can spread through improper and reuse of
needles and syringes. Unsafe use of injections accounts for 5% of
HIV, 40% of Hepatitis C and 32% of Hepatitis B virus infections
globally. Although needle stick injuries are uncommon they are a
potential problem, which can prove to be serious and are also
responsible for causing above mentioned diseases. According to the
Centers for Disease Control and Prevention (CDC), needle stick
injuries account for around 385,000 among healthcare workers in the
U.S annually. The most important goal while employing IV
administration sets and needle-free connectors is to reduce the
manipulation factor as much as possible. Some of the U.S. Food &
Drug Administration (FDA) approved needle-free IV connectors include
One-Link, CARESITE, MaxPlus, and Kendall.
“The global
needle-free IV connectors market was valued at US$ 621.1
million in 2016 and is expected to reach a robust
CAGR of 10.3% over the forecast period
(2017-2025).”
Click To
Reading More On Needle-free
IV Connectors Market
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment